A showcase of ÉTS researchers’ publications and other contributions

Biomaterials for enhanced immunotherapy


Downloads per month over past year

Cunningham, Nicholas, Lapointe, Réjean and Lerouge, Sophie. 2022. « Biomaterials for enhanced immunotherapy ». APL Bioengineering, vol. 6, nº 4. pp. 3155-3169.
Compte des citations dans Scopus : 9.

[thumbnail of Lerouge-S-2022-25993.pdf]
Lerouge-S-2022-25993.pdf - Published Version
Use licence: Creative Commons CC BY.

Download (8MB) | Preview
[thumbnail of Lerouge-S-2022-25993-accepted.pdf] PDF
Lerouge-S-2022-25993-accepted.pdf - Accepted Version
Restricted access to Repository staff only
Use licence: All rights reserved to copyright holder.

Download (5MB)


Cancer immunotherapies have revolutionized the treatment of numerous cancers, with exciting results often superior to conventional treatments, such as surgery and chemotherapy. Despite this success, limitations such as limited treatment persistence and toxic side effects remain to be addressed to further improve treatment efficacy. Biomaterials offer numerous advantages in the concentration, localization and controlled release of drugs, cancer antigens, and immune cells in order to improve the efficacy of these immunotherapies. This review summarizes and highlights the most recent advances in the use of biomaterials for immunotherapies including drug delivery and cancer vaccines, with a particular focus on biomaterials for immune cell delivery.

Item Type: Peer reviewed article published in a journal
Lerouge, Sophie
Affiliation: Génie mécanique
Date Deposited: 19 Dec 2022 19:14
Last Modified: 20 Dec 2022 15:19

Actions (login required)

View Item View Item